Deals
AmerisourceBergen to Buy Walgreens Unit for $6.5 Billion
- Deal expands U.S. drug distributor’s reach to Europe
- AmerisourceBergen shares jump as much as 6.4% in early trading
This article is for subscribers only.
AmerisourceBergen Corp. agreed to buy Walgreens Boots Alliance Inc.’s pharmaceutical wholesale businesses for about $6.5 billion in cash and stock, extending the U.S. drug distribution giant’s reach in Europe.
The deal for Walgreens’s Alliance Healthcare includes $6.275 billion in cash and 2 million in shares, the companies said in a statement Wednesday. In addition, Walgreens and AmerisourceBergen extended existing distribution agreements in the U.S. and the U.K. by several years, furthering their already close ties. Walgreens is AmerisourceBergen’s biggest shareholder with a stake of 30%.